Associate Professor, Ophthalmology, Johns Hopkins University School of Medicine
Ophthalmology
Dr. Diana V. Do, MD
|
|
Give Review
Dr. Diana V. Do works in the field of Ophthalmology. She studied medicine at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a one of the best medicals schools. University of California San Francisco School of Medicine is ranked 3 in research and 3 in primary care medicine She received awards:"CMS Meaningful Use Stage 1 Certification". Diana V. Do is also published. She has 95 publications published. The lastest publication: "Can computerization of the exercise test replace the cardiologist?'
Publications
- Aflibercept for the treatment of Diabetic macular edema.
- Aflibercept for Neovascular age-related macular degeneration.
- Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase...
- Endogenous Endophthalmitis: diagnosis, management, and prognosis.
- Nonbiological pharmacOtherapies for the treatment of diabetic macular edema.
- Effect of VitreoMacular Adhesion on Treatment Outcomes in the Ranibizumab for Edema of the Macula in Diabetes (READ-3) Study.
- Adaptive Optics Imaging of Retinal Photoreceptors Overlying Lesions in White Dot Syndrome and its Functional Correlation.
- Microperimetric assessment of retinal sensitivity in eyes with Diabetic macular edema from a phase 2 study of intravitreal aflibercept.
- Introduction to microperimetry and its use in analysis of geographic atrophy in age-related Macular degeneration.
- One-Year Outcomes of the SAVE Study: Sirolimus as a Therapeutic Approach for UVEitis.
- Variation of Choroidal thickness and vessel diameter in patients with posterior non-infectious uveitis.
- Association of retinal vessel calibre and visual outcome in eyes with Diabetic macular oedema treated with ranibizumab.
- Longitudinal comparison of visual acuity as measured by the ETDRS chart and by the potential acuity meter in eyes with Macular edema, and its relationship with retinal...
- Disparities in Visual Impairment by Immigrant Status in the United States.
- Intravitreal Aflibercept for Diabetic Macular Edema.
- RANIBIZUMAB FOR MACULAR TELANGIECTASIA TYPE 2 IN THE ABSENCE OF SUBRETINAL NeovascularIZATION.
- Driving Habits in Older Patients with Central Vision Loss.
- Factors affecting visual outcomes in patients with Diabetic macular edema treated with ranibizumab.
- Long-term Outcomes in Ranibizumab-Treated Patients With Retinal Vein Occlusion; The Role of Progression of Retinal Nonperfusion.
- A PHASE IA DOSE-ESCALATION STUDY OF THE ANTI-FACTOR D MONOCLONAL ANTIBODY FRAGMENT FCFD4514S IN PATIENTS WITH GEOGRAPHIC ATROPHY.
- Detection of new-onset Choroidal neovascularization.
- Putting theories and results into practice: managing cases.
- Implications of the comparisons of age-related Macular degeneration treatments trials on clinical practice: what have we learned?
- Association of Retinal Sensitivity to Integrity of Photoreceptor Inner/Outer Segment Junction in Patients with Diabetic Macular Edema.
- Ranibizumab for Edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment.
- Vascular disrupting agent for Neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin a-4 phosphate.
- Comparison of Time Domain and Spectral Domain Optical Coherence Tomography in Measurement of Macular Thickness in Macular Edema Secondary to Diabetic Retinopathy and R...
- The role of biologic agents in the management of non-infectious uveitis.
- Evaluation of Very High- and Very Low-Dose Intravitreal Aflibercept in Patients with Neovascular Age-Related Macular Degeneration.
- One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema.
- ScleroChoroidal Calcifications Imaged Using Enhanced Depth Imaging Optical Coherence Tomography.
- Characterization of macular lesions in punctate inner Choroidopathy with spectral domain optical coherence tomography.
- Macular sensitivity and fixation patterns in normal eyes and eyes with uveitis with and without Macular edema.
- The Relationship Between Macular Sensitivity and Retinal Thickness in Eyes With Diabetic Macular Edema.
- The DA VINCI Study: Phase 2 Primary Results of VEGF Trap-Eye in Patients with Diabetic Macular Edema.
- Importance of proper diagnosis for management: multifocal Choroiditis mimicking ocular histoplasmosis syndrome.
- Myocardial infarction and cerebrovascular accident in patients with Retinal vein occlusion.
- Antagonism of vascular endothelial growth factor for Macular edema caused by retinal vein occlusions: two-year outcomes.
- Use of Retinal procedures in medicare beneficiaries from 1997 to 2007.
- Prospective one-year study of ranibizumab for predominantly hemorrhagic Choroidal neovascular lesions in age-related macular degeneration.
- Topical mecamylamine for Diabetic macular edema.
- Retinal thickness analysis by race, gender, and age using Stratus OCT.
- Diagnostic and therapeutic challenges. Acute onset panuveitis.
- Nodular scleroChoroidopathy simulating Choroidal malignancy.
- A randomized, double-masked controlled clinical trial of Sandostatin long-acting release depot in patients with postsurgical cystoid Macular edema.
- Monitoring ocular drug therapy by analysis of aqueous samples.
- Enterococcus casseliflavus Endophthalmitis associated with a horse tail injury.
- Safety implications of Vascular endothelial growth factor blockade for subjects receiving intravitreal anti-Vascular endothelial growth factor therapies.
- A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with Neovascular age-related macular degeneration.
- Antiangiogenic approaches to age-related Macular degeneration in the future.
- Cystoid Macular edema responds to intravitreal triamcinolone and rebounds after intravitreal bevacizumab.
- Progression of Macular ischemia following intravitreal bevacizumab.
- Anti-VEGF therapeutic approaches for Diabetic macular edema.
- Diagnostic and therapeutic challenges. Granulomatous panuveitis.
- Hospitalized cardiovascular diseases in Neovascular age-related macular degeneration.
- Ranibizumab for Macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator.
- Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases Other than age-related macular degeneration.
- Recent trends in the management of rhegmatogenous Retinal detachment.
- Impact of optical coherence tomography on surgical decision making for epiretinal Membranes and vitreomacular traction.
- Punctate inner Choroidopathy: a survey analysis of 77 persons.
- Vascular endothelial growth factor is a critical stimulus for Diabetic macular edema.
- Hemoglobin A1c awareness among patients receiving eye care at a tertiary ophthalmic center.
- The impact of optical coherence tomography on surgical decision making in epiretinal membrane and vitreoMacular traction.
- Photodynamic therapy for focal retinal pigment epithelial leaks secondary to Central serous chorioretinopathy.
- Persistent Diabetic macular edema is associated with elevated hemoglobin A1c.
- Evaluation of patients with scleritis for systemic disease.
- Large subMacular hemorrhages after verteporfin therapy.
- Reversible cortical blindness in preeclampsia.
- Endothelial dystrophy, iris hypoplasia, congenital Cataract, and stromal thinning (edict) syndrome maps to chromosome 15q22.1-q25.3.
- Platelet derived growth factor inhibitors: A potential therapeutic approach for ocular Neovascularization.
- Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases.
- Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner Choroidopathy.
- Two-year outcomes of the ranibizumab for Edema of the mAcula in diabetes (READ-2) study.
- Progressive changes from idiopathi to various test meals in lean and obese cats.
- Intercellular adhesion molecule inhibitors as potential therapy for refractory uveitic Macular edema.
- RNAi-based treatment for Neovascular age-related macular degeneration by Sirna-027.
- Persistent intermediate uveitis associated with latent manifestation of facial large B-cell non-Hodgkin lymphoma.
- Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study.
- Surgery for post-vitrectomy Cataract.
- Atypical Bartonella hensalae chorioRetinitis in an immunocompromised patient.
- New therapies for Neovascular age-related macular degeneration: critical appraisal of the current evidence.
- Panuveitis in association with pseudotumor cerebri.
- Diagnostic and therapeutic challenges: panuveitis and Optic neuritis.
- Ranibizumab for the treatment of Neovascular AMD.
- Microarray analysis of gene expression in human donor corneas.
- Bevacizumab suppresses Choroidal neovascularisation caused by pathological myopia.
- The incidence of Endophthalmitis following transconjunctival sutureless 25- vs 20-gauge vitrectomy.
- An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of Vascular endothelial growth factor Trap-Eye in patients with dia...
- Common ophthalmic emergencies.
- Epithelial-mesenchymal interactions in keloid pathogenesis modulate Vascular endothelial growth factor expression and secretion.
- Distribution pattern of infrageniculate arterial obstructions in patients with diabetes mellitus and renal insufficiency - implications for reVascularization.
- Can computerization of the exercise test replace the cardiologist?
- Heart rate recovery: validation and methodologic issues.
- Clinical and exercise test predictors of all-cause mortality: results from > 6,000 consecutive referred male patients.
Schools
University Of Ca School Of Med
Johns Hopkins University School Med
Mass Gen Hospital
Procedures Preformed
- Anterior Vitrectomy
- Cataract Removal Surgery
- Ocular Prosthetics
- Repair of Retinal Detachment or Retinal Tear
- View All
Conditions Treated
- Aphakia and Other Disorders of Lens
- Benign Neoplasm of Choroid
- Benign Neoplasm of Eye
- Cataract
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
Massachusetts General Hospital -
University of California San Francisco School of Medicine
Hospital
-
Howard County General Hospital
Drug Facts
| NPI NUMBER | 1245270313 | |
| NPPES Provider LastName | DO | |
| NPPES Provider FirstName | DIANA | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 51.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1245270313 |
| Last Name Of The Provider | DO |
| First Name Of The Provider | DIANA |
| View All |
Similar Doctors
|
|
Dr. Wendy H. Bohner, MD |
|
|
Dr. Henry Jampel, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stan L. Coleman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter T. Lapinsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leeds Katzen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tania S. Marcic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph Harlan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharon Solomon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tanvi M. Shah, MD
This Doctor is OpenDoctor Recommended.
|